Last updated: May 26, 2026
- Produce USP/NF-compliant calcium chloride, potassium chloride, sodium chloride, and sodium lactate in bulk.
- Provide GMP/DMF-backed documentation when required for injectable manufacturing inputs.
Finished-dose injectable solution manufacturers
- Provide sterile IV solutions and vials/bags for hospital and distribution channels.
- Often control formulation and sterile fill-finish, reducing buyer regulatory and quality interface.
Contract sterile fill-finish and packaging providers
- Supply sterile drug product under CMO agreements.
- Useful when the buyer has a local bulk sourcing strategy but needs sterile packaging and release.
Supplier examples that frequently appear in pharma supply chains
- Thermo Fisher Scientific (including Sigma-Aldrich distribution channels and life sciences GMP sourcing): inorganic salts and injectable-grade inputs through commercial supply and regulated product programs.
- Fresenius Kabi: IV fluids and electrolyte products, including sodium chloride and potassium/sodium electrolyte combinations in common hospital pack formats.
- Baxter: IV therapy and electrolyte solutions for hospital distribution.
- ICU Medical: injectable solutions and IV products, including electrolyte-containing formulations depending on portfolio.
Note: The salts listed (calcium chloride, potassium chloride, sodium chloride, sodium lactate) are frequently supplied both as bulk API and as sterile finished-dose IV fluids, and the “supplier” depends on whether you buy API or finished drug product.
What suppliers provide USP/NF injectable-grade sodium chloride and electrolyte salts?
Featured snippet answer: For USP/NF injectable-grade requirements, suppliers typically provide a combination of: USP/NF compliance statements, sterility and endotoxin documentation where applicable (for finished sterile solutions), and GMP documentation for bulk API.
Bulk API sourcing: what to look for
- USP/NF monographs alignment for each salt (e.g., Sodium Chloride, Potassium Chloride).
- GMP manufacturing for injectable-grade API (often supported by audits and documentation packages).
- Traceability and impurity control suited to sterile manufacturing feeds (metals, sulfate, heavy metals, pH, etc.).
Finished-dose sourcing: what to look for
- Sterile solution manufacturing under CGMP.
- Endotoxin and sterility testing appropriate to the dosage form.
- Container/closure suitability (single-dose vials, minibags, large-volume solutions).
Which suppliers dominate finished-dose IV solutions containing calcium chloride or potassium chloride?
Featured snippet answer: Portfolio leaders in hospital IV and electrolyte solutions include global sterile manufacturers with broad IV ecosystems. Fresenius Kabi and Baxter are recurring reference points for electrolyte-containing sterile products; additional regional sterile suppliers and CMOs fill the rest of the market.
Typical finished-dose formats
- Calcium chloride injection: vials, often used for electrolyte correction and emergency indications.
- Potassium chloride injection: vials and bags, with dosing concentration variants.
- Sodium chloride injection (0.9% NS): vials and large-volume bags.
- Sodium lactate injection/solutions: typically used for alkalinizing and electrolyte management, with concentration-specific formulations.
Are there different supplier lists for bulk calcium chloride vs sterile calcium chloride injection?
Yes. Bulk calcium chloride procurement is usually a bulk inorganic API sourcing exercise. Sterile calcium chloride injection procurement is a drug product sourcing exercise.
Bulk calcium chloride supplier set tends to include
- Inorganic chemical producers with GMP documentation for injectable-grade bulk salts.
- Distributors that route through GMP API programs.
Sterile calcium chloride injection supplier set tends to include
- Finished sterile drug product manufacturers.
- Regional hospital distributors sourcing from global IV solution manufacturers.
What CMO and fill-finish suppliers support sterile electrolyte solutions?
Featured snippet answer: CMO sterile supply is concentrated among large sterile fill-finish networks that handle IV solutions, vials, and bags. These providers sell services rather than a single fixed salt.
CMO scope for these salts
- Sterile solution filling for sodium chloride and electrolyte mixtures.
- Vial filling and packaging for calcium chloride and potassium chloride.
- GMP-compliant quality systems and release testing under contract.
How do supplier selection and documentation differ for sodium lactate vs sodium chloride?
Sodium lactate has narrower therapeutic roles and different manufacturing control points than sodium chloride, which is ubiquitous.
Sodium lactate supplier considerations
- Stronger focus on quality characterization of lactate content, isomer/impurity control, and stability.
- Container compatibility and stability during storage for specific concentrations.
Sodium chloride supplier considerations
- Strong focus on impurity limits and consistent dissolution and pH control for sterile IV use.
- Broad supplier ecosystem with mature documentation flows.
What are the key quality and regulatory interfaces when sourcing injectable electrolyte salts?
Featured snippet answer: The decisive interface is whether you buy bulk API or sterile finished drug product, because the documentation and release responsibilities differ.
If buying bulk API
- GMP manufacturing controls.
- Batch traceability.
- CoA aligned to injectable needs.
- Impurity profile appropriate for sterile manufacturing.
If buying sterile finished drug product
- Sterile manufacturing under CGMP.
- Sterility and endotoxin release.
- Container closure integrity and stability program.
- Labeling and distribution compliance.
Supplier risk and continuity: where shortages tend to concentrate
Featured snippet answer: Shortages and continuity risks concentrate where supply depends on specific production capacity, salt purification steps, and sterile fill-finish capacity rather than on the salt itself.
Practical risk vectors
- Sterile fill-finish bottlenecks
- Batch release delays due to quality system testing
- Raw material variability for high-purity grades
Key supplier short-list framework for procurement teams
Featured snippet answer: Build two-tier sourcing: primary suppliers for continuity plus secondary suppliers that can qualify quickly through documentation and quality review.
Tier 1: primary supplier(s)
- Provide injectable-grade bulk salts or finished sterile solutions consistently.
- Maintain documented GMP and CoA availability.
Tier 2: alternate supplier(s)
- Provide equivalent grades with transferable documentation.
- Have known performance in regulated pharmaceutical supply chains.
What commercial channels supply these salts to pharma manufacturers and hospitals?
Pharma manufacturer supply
- Direct sourcing from GMP bulk API producers or regulated ingredient programs.
- Through approved distributors with compliance documentation.
Hospital supply
- Direct from established IV solution manufacturers or national distributors.
- Often sourced as finished sterile vials/bags.
How to compare supplier capability between inorganic salt producers and sterile drug product manufacturers
Featured snippet answer: If your requirement is dosing-ready sterile electrolyte solutions, compare sterile product manufacturers. If your requirement is feeding a formulation line, compare bulk API producers.
| Procurement target |
Best supplier archetype |
What to evaluate first |
| Bulk calcium chloride |
Inorganic API producer |
Injectable-grade GMP, impurity profile, CoA traceability |
| Bulk potassium chloride |
Inorganic API producer |
KCl grade consistency, metals/sulfate limits, CoA alignment |
| Bulk sodium chloride |
Inorganic API producer |
Consistency, USP/NF compliance, impurity controls |
| Bulk sodium lactate |
Inorganic API producer |
Lactate assay control, stability and impurities |
| Calcium chloride injection |
Sterile drug product manufacturer or CMO |
Sterility/endotoxin testing, container, stability, release |
| Potassium chloride injection |
Sterile drug product manufacturer or CMO |
Dose concentrations, packaging formats, supply continuity |
| Sodium chloride 0.9% injection |
Sterile drug product manufacturer |
Large-volume availability, supply reliability |
| Sodium lactate injection/solution |
Sterile drug product manufacturer |
Concentration formats and stability program |
Key Takeaways
- Injectable electrolyte salt sourcing splits into bulk API supply and sterile finished-dose supply; supplier lists differ materially.
- Large global sterile drug product players with IV portfolios, such as Fresenius Kabi and Baxter, are common sources for finished IV solutions; Thermo Fisher Scientific is a recurring reference for regulated inorganic salt supply via GMP programs and distribution channels.
- Procurement continuity depends more on purification grade control for bulk salts and sterile fill-finish capacity for finished injectables than on the general availability of the salts themselves.
- The fastest qualification path comes from suppliers that already operate under GMP systems compatible with sterile manufacturing needs and can deliver consistent CoA and batch traceability.
FAQs
1) Who supplies pharmaceutical-grade sodium chloride for sterile manufacturing as bulk API?
Bulk USP/NF-aligned injectable-grade sodium chloride is typically supplied by established inorganic chemical producers and regulated ingredient supply programs, with documentation provided for injectable use.
2) Which companies sell calcium chloride injection in vials and packaged IV formats?
Finished calcium chloride injection is generally supplied by global sterile manufacturers and regional sterile product suppliers with vial-filling capabilities and established hospital distribution.
3) Are sodium lactate suppliers different from sodium chloride suppliers?
Yes. Sodium lactate supply emphasizes lactate assay and specific impurity/stability controls, while sodium chloride has a broader, more commoditized grade ecosystem.
4) Can CMOs supply sterile fill-finish for electrolyte solutions using buyer-provided bulk salts?
Yes. Many sterile fill-finish providers contract on formulation and packaging while handling sterility and release testing under GMP for the finished drug product.
5) What documentation is most critical when switching electrolyte salt suppliers?
For bulk API switches: GMP, CoA, batch traceability, and impurity profile. For finished-dose switches: sterility/endotoxin release, stability data, and container closure integrity documentation.
References
- Fresenius Kabi. Product portfolio and manufacturing information (company website).
- Baxter. IV therapy and electrolyte product information (company website).
- ICU Medical. IV solutions and injectable product information (company website).
- Thermo Fisher Scientific. Regulated chemical and life sciences supply programs (company website).
